Mason Street Advisors’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-30,189
Closed -$4.72M 1459
2020
Q4
$4.72M Sell
30,189
-594
-2% -$76.3K 0.08% 239
2020
Q3
$3.52M Sell
30,783
-743
-2% -$80.2K 0.07% 289
2020
Q2
$3.54M Sell
31,526
-47
-0.1% -$4.99K 0.07% 266
2020
Q1
$2.83M Hold
31,573
0.07% 288
2019
Q4
$3.42M Sell
31,573
-372
-1% -$39.8K 0.07% 332
2019
Q3
$3.13M Sell
31,945
-35
-0.1% -$3.94K 0.06% 343
2019
Q2
$4.19M Buy
31,980
+99
+0.3% +$12.8K 0.09% 238
2019
Q1
$4.31M Buy
31,881
+428
+1% +$53.2K 0.09% 234
2018
Q4
$3.06M Buy
31,453
+124
+0.4% +$14.7K 0.07% 280
2018
Q3
$4.36M Buy
31,329
+112
+0.4% +$14.1K 0.09% 221
2018
Q2
$3.88M Buy
31,217
+337
+1% +$39.4K 0.08% 231
2018
Q1
$3.44M Sell
30,880
-239
-0.8% -$28.6K 0.08% 268
2017
Q4
$3.72M Buy
31,119
+137
+0.4% +$16.7K 0.08% 244
2017
Q3
$4.35M Sell
30,982
-184
-0.6% -$25K 0.1% 194
2017
Q2
$3.79M Buy
31,166
+126
+0.4% +$14.7K 0.09% 221
2017
Q1
$3.76M Buy
31,040
+364
+1% +$46.9K 0.1% 213
2016
Q4
$3.75M Buy
30,676
+340
+1% +$41.6K 0.1% 203
2016
Q3
$3.72M Buy
30,336
+162
+0.5% +$20.9K 0.11% 193
2016
Q2
$3.52M Buy
30,174
+165
+0.5% +$23.4K 0.1% 200
2016
Q1
$4.18M Buy
30,009
+573
+2% +$84.1K 0.13% 155
2015
Q4
$5.62M Buy
29,436
+175
+0.6% +$30.6K 0.18% 112
2015
Q3
$4.58M Buy
29,261
+431
+1% +$78.6K 0.15% 127
2015
Q2
$5.21M Buy
28,830
+2,796
+11% +$483K 0.16% 122
2015
Q1
$4.51M Sell
26,034
-69,188
-73% -$12.5M 0.14% 142
2014
Q4
$17.6M Sell
95,222
-148
-0.2% -$27.4K 0.12% 211
2014
Q3
$15.8M Sell
95,370
-47
-0% -$7.72K 0.12% 205
2014
Q2
$14.9M Sell
95,417
-11,308
-11% -$1.79M 0.12% 218
2014
Q1
$16.2M Sell
106,725
-29,920
-22% -$4.76M 0.13% 200
2013
Q4
$18.2M Sell
136,645
-4,988
-4% -$599K 0.15% 183
2013
Q3
$16.5M Sell
141,633
-42,297
-23% -$4.64M 0.19% 151
2013
Q2
$17M Buy
+183,930
New +$17.7M 0.19% 143

Other funds holding ALXN